Delivery Order SPE2DB22D1017-SPE2DB25FYPGD
- Not listed
- The Defense Logistics Agency awarded a $19,801.59 firm fixed price delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch in quantities of 30 units. The order was competitively awarded with no set-aside designation and has an ultimate completion date of July 21, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,722.08 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product. This competitive, firm fixed-price delivery order was issued on August 18, 2025, with an ultimate completion date of August 19, 2025. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s under a firm fixed-price contract with a ceiling value of $3,380.41. This non-set-aside delivery order was awarded on August 1, 2025, with an ultimate completion date of August 4, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order represents a child contract action under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,361.69 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product. This firm fixed price delivery order, awarded on July 29, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract involves no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30-count units under a firm fixed-price contract with a ceiling value of $4,246.98. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of July 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,726.70 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of July 22, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered...
- The Defense Logistics Agency awarded a delivery order valued at $2,363.52 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of August 25, 2025. This competitive award uses firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The work will be performed at the vendor's...
- The Defense Logistics Agency awarded a delivery order valued at $8,508.28 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contractor's corporate office is located in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $19,570.26 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product. This firm fixed price contract was competitively awarded without set-aside designation and carries an ultimate completion date of August 19, 2025. The delivery order will be fulfilled from AmerisourceBergen's corporate office operations in Conshohocken, Pennsylvania, which serves as the company's headquarters and...
- The Defense Logistics Agency awarded a $14,830.64 delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of August 20, 2025. This non-set-aside contract utilizes firm fixed pricing and was competitively awarded on August 19, 2025. The product will be delivered to the prime contractor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYPGDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,555.24 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with performance at the company's Conshohocken, Pennsylvania location. This firm fixed-price delivery order, awarded on August 27, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026. The delivery order carries no set-aside designation and was competitively awarded, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for the Defense Logistics Agency's medical supply chain, providing an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's federal contract awards demonstrate consistent success in fulfilling military and veteran healthcare system needs through open competition, with delivery orders employing firm fixed pricing structures. This particular delivery order for topical pain management medication supports the DLA's broader mission to supply pharmaceutical products for military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 8/27/25 |